Quick Search:       Advanced Search
    Click here to download the full text
Citation of this paper:.[J].Chinese Journal of Clinical Medicine,2017,24(6):930-934
Hits: 2039
Download times: 975
Author NameAffiliation
李峰1,李缨1*,王蕾1,沈波2,邹建洲2,高秋凤1,徐炜新3 1.上海市嘉定区中心医院肾脏内科上海 201800 2.复旦大学附属中山医院肾脏内科上海 200032 3.上海市嘉定区中心医院检验科上海 201800 
Abstract:Objective:To compare the clearance effect on serum fibroblast growth factor-23 (FGF-23) between traditional hemodialysis (HD) and HD combined with hemoperfusion (HP).Methods:Totally 60 maintenance hemodialysis (MHD) patients from January 2016 to June 2016 in Central Hospital of Jiading District in Shanghai were randomly divided into HD group (30 cases) and HD+HP group (30 cases). The patients in HD group underwent HD (3 times/week, 4 h/time), the patients in HD+HP group underwent HD (2 times/week, 4 h/time), HD combined with HP (1 time/week, 2 h/time) then change into HD for 2 h. The treatment lasted for 6 months. The data of serum phosphorus (P), calcium (Ca), urea nitrogen (BUN), creatinine (Scr), intact parathyroid hormone (iPTH), FGF-23 levels were collected before and after study.Results:There were no significantly differences of BUN, Scr, Ca, P, iPTH, FGF-23 between HD group and HD+HP group at the beginning of study. After 6 months treatment, the levels of BUN and Scr were significantly decreased (all P<0.05) in both groups. The levels of P, iPTH, and FGF-23 were significantly decreased after treatment in HD+HP group (all P<0.05). The levels of P, iPTH, and FGF-23 in HD+HP group were significantly lower than those in HD group (P<0.05) at the end of study, and no significantly differences of Hb, Alb, BUN, Scr were found between groups.Conclusions:Compared with HD, HD combined with HP treatment can significantly reduce the levels of P, iPTH, and FGF-23 in serum of MHD patients.
keywords:hemodialysis  hemoperfusion  fibroblast growth factor-23
HTML  View Full Text  View/Add Comment  Download reader